Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (211-220 of 270) with videos related to

Pageof 27
Sort By:
Oncogene|August 30, 2019
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancerSen Zhu, Dongyu Zhao, Chao Li, et al.
Cancer Research|March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate CancerXinpei Ci, Jun Hao, Xin Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Nature Communications|January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancerTakuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancerSajni Josson, Murali Gururajan, Peizhen Hu, et al.
The Journal of Clinical Investigation|December 18, 2019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsLucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Oncogene|July 18, 2019
Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancerNora Pällmann, Marte Livgård, Martina Tesikova, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
Pageof 27

Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
Oncogene|August 30, 2019
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancerSen Zhu, Dongyu Zhao, Chao Li, et al.
Cancer Research|March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate CancerXinpei Ci, Jun Hao, Xin Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Nature Communications|January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancerTakuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancerSajni Josson, Murali Gururajan, Peizhen Hu, et al.
The Journal of Clinical Investigation|December 18, 2019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsLucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Oncogene|July 18, 2019
Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancerNora Pällmann, Marte Livgård, Martina Tesikova, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
Pageof 27